Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy.
10.1016/j.apsb.2022.09.016
- Author:
Ze MI
1
;
Qing YAO
1
;
Yan QI
2
;
Jinhai ZHENG
3
;
Jiahao LIU
1
;
Zhenguo LIU
1
;
Hongpei TAN
1
;
Xiaoqian MA
1
;
Wenhu ZHOU
1
;
Pengfei RONG
1
Author Information
1. Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
2. Department of Pathology, Shihezi University School of Medicine and the First Affiliated Hospital to Shihezi University School of Medicine, Shihezi 832003, China.
3. School of Biomedical Sciences, Hunan University, Changsha 410082, China.
- Publication Type:Journal Article
- Keywords:
Blood–brain barrier;
Chemo-sensitization;
Doxorubicin;
Glioma;
Neutrophil hitchhiking;
Outer membrane vesicles;
P-glycoprotein;
Salmonella
- From:
Acta Pharmaceutica Sinica B
2023;13(2):819-833
- CountryChina
- Language:English
-
Abstract:
Chemotherapy is an important adjuvant treatment of glioma, while the efficacy is far from satisfactory, due not only to the biological barriers of blood‒brain barrier (BBB) and blood‒tumor barrier (BTB) but also to the intrinsic resistance of glioma cells via multiple survival mechanisms such as up-regulation of P-glycoprotein (P-gp). To address these limitations, we report a bacteria-based drug delivery strategy for BBB/BTB transportation, glioma targeting, and chemo-sensitization. Bacteria selectively colonized into hypoxic tumor region and modulated tumor microenvironment, including macrophages repolarization and neutrophils infiltration. Specifically, tumor migration of neutrophils was employed as hitchhiking delivery of doxorubicin (DOX)-loaded bacterial outer membrane vesicles (OMVs/DOX). By virtue of the surface pathogen-associated molecular patterns derived from native bacteria, OMVs/DOX could be selectively recognized by neutrophils, thus facilitating glioma targeted delivery of drug with significantly enhanced tumor accumulation by 18-fold as compared to the classical passive targeting effect. Moreover, the P-gp expression on tumor cells was silenced by bacteria type III secretion effector to sensitize the efficacy of DOX, resulting in complete tumor eradication with 100% survival of all treated mice. In addition, the colonized bacteria were finally cleared by anti-bacterial activity of DOX to minimize the potential infection risk, and cardiotoxicity of DOX was also avoided, achieving excellent compatibility. This work provides an efficient trans-BBB/BTB drug delivery strategy via cell hitchhiking for enhanced glioma therapy.
